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ABSTRACT
Background: Multiple sclerosis (MS) as a chronic disease of the central nervous system have 
the very prevalent in worldwide. Its epidemiology is different region by region, and most of 
the geographical and environmental factors may play a role in its incidence. We designed this 
study to analyze demographic characteristics of MS. Methods: This survey has been conducted 
in East-Azerbaijan province, northwest of Iran. Prevalence of the MS has been measured using 
data from Committee for Diagnosis and Treatment of MS in 2014. Age, gender, and type of the 
disease also had been investigated in this research. Independent T-Test, Chi-square, Pearson and 
Fisher’s exact test used to analyze data by SPSS21. Results: We had 2774 MS patients in 2014. 
Of them, 726 (26%) were male and 2003 (73%) were female. The mean age of males and females 
was 38±9 years and 37.09±9 years, respectively. The mean age of male patients significantly 
was higher than females (P=0.001). We measured 73.26 prevalence per 100000 populations in 
East-Azerbaijan province. Conclusion: Prevalence of the MS showed a significant increase 
in 5 years compared to previous studies. Because of disease’s dishabilitating entity more 
interventional investigations are recommended to perform in preventing disease incidence or 
improving the quality of life of sufferers and increasing their life expectancy.
INTRODUCTION
Multiple sclerosis (MS) as one of the chronic diseases at-
tacks central nervous system (CNS) (1). It has an unknown 
origin, but genetic and immunological factors play a role in 
the pathophysiology of illness (2).
For the first time, MS was introduced in 1837 by Car-
swell and Caruneiheir, and then histology of its lesions has 
been described (3,4). Three years later, clinical diagnosis for 
MS has been identified by Frerichs (5). Association between 
histopathological changes and its clinical findings explained 
for the first time in 1868 (6).
National MS Association of America has reported that 
2.5 million people are suffering from this disease all around 
the world. Iranian MS Society reported 50000 MS patients 
in Iran during 2007 (7-10). Mean prevalence of the MS have 
been reported 15-30 in 100000 populations according to 
Payamani’s study, but 55-98 in 100000 reported by Elhami 
et al. in Tehran, the capital of Iran (13,14).
Hashemilar et al. reported 27.7 in 100000 for the MS in 
East-Azerbaijan province, northwest of Iran in 2009 (15). 
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This condition has variable prevalence in a different region, 
and some geographical risk factors seem to affect the inci-
dence. Hence, this study was aimed to analyze MS demo-
graphic characteristics in East-Azerbaijan province in 2014, 
which has 47.830 km2 area and about 3.7 million populations 
in the northwest of Iran (16).
METHODS
This cross-sectional study has been conducted in East-Azer-
baijan province in Iran. This country has about 78 million 
population, and 3.7 million of them are East-Azerbaijan res-
idents based on the national census in 2011.
Patient Selection
The study population was all the MS patients in this prov-
ince during 2014. All the sufferers of this disease are be-
ing registered in Committee for Diagnosis and Treatment of 
MS (CDTMS) which operates numbers attends of Neurol-
ogy Department of Tabriz University of Medical Sciences. 
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Neurologists in East-Azerbaijan that diagnose the MS refer 
their patients to this committee to confirm the diagnosis and 
patients are being registered after further evaluations and 
diagnosis approval. All the patients that were registered in 
CDTMS and were being treated in 2014 with confirmed di-
agnosis of MS included. The diagnosis and classification of 
patients were based on McDonald criteri (The McDonald 
criteria use magnetic resonance imaging evidence extensive-
ly and can allow for a diagnosis of MS to be made by one re-
lapse, given the right evidence from scans).
Data Collection
Data of the patients was gathered by researcher made check-
list with research variables including, patient demographics, 
the age of disease onset and clinical form of the disease. 
Checklists were filled from an electronic database of pa-
tients’ medical recordings at CDTMS office in Tabriz Uni-
versity of Medical Sciences.
Data Analyses
Data have been entered in SPSS software version 21, and 
descriptive statistics were used to analyze data (mean, stan-
dard deviation, percentage, maximum, minimum, etc.). 
Independent T-test was performed to compare means. Chi-
square was employed by Pearson and Fisher exact tests to 
compare qualitative parametrical and non-parametrical data, 
respectively. A p-value less than 0.05 have been considered 
as significant.
RESULTS
Our study included all MS sufferers up to 2014, and its prev-
alence was meagered 73.26 per 100000 people. East-Azer-
baijan had 3.6 million population, and it had been raised to 
3.7 million in our study.
Also, the source of data and inclusion criteria were the 
same in both studies, the prevalence of the disease showed 
dramatically increase in 5 years (Figure 1). The frequency of 
the disease has been raised from 1000 to 2779 (269 to 726 
in male and 731 to 2003 in female). Indeed, we had 2774 
MS patients in 2014 in East-Azerbaijan. Of them, 726 (26%) 
were male and 2003 (73%) were female and female to male 
ratio was 2.76. The mean age of males and female was 
38±9 years and 37.09±9 years, respectively.
The mean age in male patients significantly was high-
er than in females (P=0.001). The mean age of diagnosis in 
males and female was 30±9 and 29±9 years, respectively. 
There was a significant difference between mean age of di-
agnosis in male and female patients (P=0.015).
Thirteen- three (5.33%) of males and 97 (5.69%) of fe-
males had early onset MS, which was the significantly high-
er rate in female (P=0.000). One hundred and ninety (7%) 
patients were illiterate, 795 (29%) had primary education 
degrees, 885 (32%) had secondary education degrees, and 
828 (30%) had university college degrees. Among the pa-
tients, 2554 (95%) had the ability to walk, but 127 (4%) 
didn’t (Figure 2).
DISCUSSION
Our result showed that most of MS patients are females and 
its being diagnosed in 1-2 years earlier in this gender same 
as other reports (17,18,19,20). The mean age of diagnosis 
was in the late twenties both in men and women in this study, 
which was lesser and higher than Qom and Tehran studies, 
respectively (21-22).
In spite of geographical features, it could be understood 
that the disease is diagnosed earlier in more developed re-
gions (23-24). About 5 percent of patients had early onset 
of the MS that had been symptomatic for ages younger than 
sixteen years old. Also, the prevalence of early onset dis-
ease was higher in women; it consists lower number of the 
patients in sum. Our study replicated findings of other in-
vestigations that show more incidence of MS in older ages. 
Female to male ratio was lower than most of other studies 
conducted in Iran (25-27). It indicates that gender distribu-
tion of the MS is more equipoised in our area compared to 
other provinces of our country, but it does not degrade more 
prevalence of MS in females (21,22,28). The mean age of the 
patients and age of their diagnosis was significantly higher in 
males than females same as previous studies (15,21,29). The 
MS was more common (50.04%) in 25-34 years age group 
than the other age groups. In Saei’s report, most of the pa-
tients (38%) were between 30 to 35 years age group, but fur-
Figure 1. Prevalence of MS throught 5 years Figure 2. Education degree of patients
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ther information has not been mentioned in their article (22). 
Some environmental and infectious factors have been men-
tioned as the risk factors such as smoking and Epstein–Barr 
virus exposure (20). In some other studies correlation of Vit 
D deficiency and sun exposure with risk of MS has been 
investigated (30-32) and reported that Vit D deficiency or 
lower sunlight exposure in childhood might make people 
susceptible to MS in adolescence  (33). However, the mech-
anism of these factors in MS pathophysiology is not clearly 
understood, and additional studies should be performed to 
evaluate underlying mechanisms (34,35). Unfortunately, in 
the current study, we could not study risk factors of MS due 
to some limitations.
In our study, relapsing-remitting MS was the most 
common type that was similar to other reports (14, 21). In 
2009, Hashemilar et al. had a survey with the same study 
method and place and reported MS prevalence was 27.7 
per 100000 people in East-Azerbaijan province with the 3.6 
million populations according to 2006 national census (15). 
This increase in MS prevalence in 5 years might have several 
reasons such as changing in dietary and habitual patterns and 
developing westernization. If we look optimistically, this 
significant increase in prevalence can also be due to the im-
provement of diagnostic methods such as developing mag-
netic resonance imaging techniques and even overdiagnosis.
Gender distribution of the MS was the same in both sur-
veys, which suggests that regardless of rising prevalence, its 
growth is balanced.
CONCLUSION
The MS involves young adults that play a major role in 
developing countries and growing economies. Because of 
disease’s dishabilitating entity more interventional investi-
gations are recommended to perform in preventing disease 
incidence or improving the quality of life of sufferers and 
increasing their life expectancy.
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